Displaying 9201 - 9220 of 38124
8 de Nov de 2017
Nov08
Evento
Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics
The Hatch-Waxman Act, passed by Congress more than 30 years ago, provides a regulatory and judicial framework to expedite generic entry into U.S. prescription drug markets. For many drugs, the Act has...
Nov08
Evento
Acting Chmn. Ohlhausen keynote remarks at Understanding Competition in Prescription Drug Markets event
FTC Acting Chairman Maureen K. Ohlhausen will deliver keynote remarks at the FTC Workshop, “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics.” Constitution...
Nov08
Evento
Hearing in the matter of Impax Laboratories, Inc.
FTC Administrative Law Judge Michael D Chappell will hear the matter of Impax, Docket No. 9373. FTC Headquarters, 600 Pennsylvania Ave. NW, Room 532, Washington, DC
Case Timeline Item
TaxSlayer, In the Matter of (timeline item) - November 8, 2017
Date
File
Complaint
(63.4 KB)
File
Decision and Order
(44.17 KB)
Case Timeline Item
KFJ Marketing, LLC (timeline item) - November 8, 2017
Date
File
Appendix A
(273.7 KB)
Case Timeline Item
Impax Laboratories, Inc., In the Matter of (timeline item) - November 8, 2017
Date
File
Case Timeline Item
Sears Holdings Management Corporation, a corporation, in the Matter of (timeline item) - November 8, 2017
Date
File
Petition to Reopen and Modify Final Order
(459.4 KB)
7 de Nov de 2017
Public Statement
Opening Remarks for the 2017 DSA Fall Conference
Date
File
Opening Remarks for the 2017 DSA Fall Conference
(308.82 KB)
Para su Difusión
FTC to Hold Workshop on Examining Competition Issues Related to Prescription Drug Markets
Fecha
WHAT: The Federal Trade Commission will host a workshop, “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics”. Acting FTC Chairman Maureen K. Ohlhausen and U.S...
Para su Difusión
FTC Staff Opinion: Crouse Health Hospital’s Proposed Rx Program Is Exempt from Robinson-Patman Act
Fecha
The staff of the Federal Trade Commission has issued an opinion advising Crouse Health Hospital that an exemption under the Non-Profit Institutions Act, or NPIA, applied to its proposal to sell...
Nov07
Evento
The Effects of Occupational Licensure on Competition, Consumers, and the Workforce: Empirical Research and Results
On November 7, 2017, the Federal Trade Commission’s Economic Liberty Task Force hosted a roundtable to examine empirical evidence on the effects of occupational licensure.Licensing restrictions –...
Nov07
Evento
Acting Chmn. Ohlhausen opening remarks at FTC Economic Liberty Task Force’s second public roundtable
FTC Acting Chairman Maureen K. Ohlhausen will deliver opening remarks at the FTC Economic Liberty Task Force’s second public roundtable, “The Effects of Occupational Licensure on Competition...
Nov07
Evento
Hearing in the matter of Impax Laboratories, Inc.
FTC Administrative Law Judge Michael D Chappell will hear the matter of Impax, Docket No. 9373. FTC Headquarters, 600 Pennsylvania Ave. NW, Room 532, Washington, DC
Nov07
Evento
Cmr. McSweeny debate at the Web Summit Conference
FTC Commissioner Terrell McSweeny will participate in a debate at the Web Summit Conference on – “We should be prepared to give up our privacy for security.” Lisbon, Portugal, 11:55am GMT
Case Timeline Item
Impax Laboratories, Inc., In the Matter of (timeline item) - November 7, 2017
Date
File
Letter From Markus H. Meier, Assistant Director, Bureau of Competition, Concerning Crouse Health Hospital's Proposal To Sell Discounted Pharmaceutical Products to the Employees, Retirees, and Their Dependents of Its Affiliate, Dated October 20, 2017
Date
Letter From Markus H. Meier, Assistant Director, Health Care Division, Bureau of Competition, to Jennifer R. Bolster, Esq., Hancock Estabrook, LLP, Concerning Crouse Health Hospital's Proposal To Sell...
Displaying 9201 - 9220 of 38124